News + Events

View recent news, press releases, and events

Explore by Category

Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled Health Care Model

September 14, 2021

Targeted testing run rate of 300 diabetic kidney disease patients per week in calendar Q4 2021 NEW YORK and SALT LAKE CITY, September 14, 2021 – Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount…

News

Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX Testing at Primary Care Level

August 26, 2021

News

KidneyIntelXTM Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time

June 28, 2021

News

Leadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX Deployment

June 07, 2021

News

Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care

June 03, 2021

News

Atrium Health, Wake Forest Baptist Health, Wake Forest School of Medicine and Renalytix Partner to Advance Kidney Health

May 20, 2021

News

U.S. General Services Administration Grants 10-Year Governmentwide Contract for RenalytixAI KidneyIntelX Testing

April 22, 2021

News

KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS)

April 20, 2021

News

Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions

April 08, 2021

News

Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure

April 05, 2021